PRKCD and diabetes mellitus: We envision steady progress in this field that would fill in the gaps in our current understanding of the CARD9-PKCδ signaling module in the onset of metabolic dysfunction in islet β-cell dysfunction and the loss of functional β-cell mass in diabetes.